Raquel Manso-Calderón1,2,3, Purificación Cacabelos-Pérez4,5, María D Sevillano-García4, María E Herrero-Prieto6,7, Rogelio González-Sarmiento8,9. 1. Department of Neurology, Complejo Asistencial Universitario de Salamanca (CAUSA), Paseo San Vicente 58-182, 37007, Salamanca, Spain. ramancalde@yahoo.es. 2. Division of Neurology, Department of Internal Medicine, Complejo Asistencial de Ávila, Ávila, Spain. ramancalde@yahoo.es. 3. Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain. ramancalde@yahoo.es. 4. Department of Neurology, Complejo Asistencial Universitario de Salamanca (CAUSA), Paseo San Vicente 58-182, 37007, Salamanca, Spain. 5. Department of Neurology, Hospital Clínico Universitario de Santiago (CHUS), A Coruña, Spain. 6. Division of Neurology, Department of Internal Medicine, Complejo Asistencial de Ávila, Ávila, Spain. 7. Division of Neurology, Department of Internal Medicine, Hospital El Bierzo de Ponferrada, León, Spain. 8. Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain. 9. Molecular Medicine Unit, Department of Medicine, University of Salamanca, Salamanca, Spain.
Abstract
OBJECTIVES: Behavioural and psychological symptoms (BPS) worsen quality of life and increase institutionalization in dementia, but the relationship between BPS and vascular burden on neuroimaging is unclear. Our aim is to explore whether the profile of BPS differs between patients with large-vessel or cortical vascular dementia (cVaD), small-vessel or subcortical vascular dementia (sVaD) and Alzheimer's disease (AD). METHODS: The BEVASDE study comprised 806 demented patients (cVaD-136, sVaD-184, AD-486) recruited from outpatient consultations in Salamanca and Avila, Spain. The Clinical Dementia Rating Scale (CDR) and the 12-item Neuropsychiatric Inventory (NPI) were used to evaluate dementia severity and BPS. RESULTS: BPS were reported in 98.5%, 97.3% and 96.9% of the cVaD, sVaD and AD cases, respectively. The median NPI score was 36 in both cVaD and sVaD and 34 in AD, with a median number of four symptoms per patient. The most frequent disorders were depression (64.4%), apathy (61.8%) and sleep disturbance (60.5%). Multivariate regression analyses after controlling for possible confounders showed a higher risk of euphoria (p = 0.011), apathy (p = 0.007), irritability (p = 0.002) and sleep disturbance (p = 0.020) in cVaD than in AD and more apathy (p = 0.0001) and irritability (p = 0.0001) in sVaD than in AD. In contrast, AD subjects had a higher risk of delusions (p = 0.007) and hallucinations (p = 0.023) than patients with cVaD as well as more aberrant motor behaviour than both cVaD (p = 0.0001) and sVaD (p = 0.003). CONCLUSION: BPS are common in dementia and may help in differential diagnosis of the various subtypes. We should inquire about them and treat as necessary.
OBJECTIVES: Behavioural and psychological symptoms (BPS) worsen quality of life and increase institutionalization in dementia, but the relationship between BPS and vascular burden on neuroimaging is unclear. Our aim is to explore whether the profile of BPS differs between patients with large-vessel or cortical vascular dementia (cVaD), small-vessel or subcortical vascular dementia (sVaD) and Alzheimer's disease (AD). METHODS: The BEVASDE study comprised 806 demented patients (cVaD-136, sVaD-184, AD-486) recruited from outpatient consultations in Salamanca and Avila, Spain. The Clinical Dementia Rating Scale (CDR) and the 12-item Neuropsychiatric Inventory (NPI) were used to evaluate dementia severity and BPS. RESULTS:BPS were reported in 98.5%, 97.3% and 96.9% of the cVaD, sVaD and AD cases, respectively. The median NPI score was 36 in both cVaD and sVaD and 34 in AD, with a median number of four symptoms per patient. The most frequent disorders were depression (64.4%), apathy (61.8%) and sleep disturbance (60.5%). Multivariate regression analyses after controlling for possible confounders showed a higher risk of euphoria (p = 0.011), apathy (p = 0.007), irritability (p = 0.002) and sleep disturbance (p = 0.020) in cVaD than in AD and more apathy (p = 0.0001) and irritability (p = 0.0001) in sVaD than in AD. In contrast, AD subjects had a higher risk of delusions (p = 0.007) and hallucinations (p = 0.023) than patients with cVaD as well as more aberrant motor behaviour than both cVaD (p = 0.0001) and sVaD (p = 0.003). CONCLUSION:BPS are common in dementia and may help in differential diagnosis of the various subtypes. We should inquire about them and treat as necessary.
Authors: Yves Rolland; Pierre Payoux; Valérie Lauwers-Cances; Thierry Voisin; Jean Paul Esquerré; Bruno Vellas Journal: Int J Geriatr Psychiatry Date: 2005-09 Impact factor: 3.485
Authors: M Caputo; R Monastero; E Mariani; A Santucci; F Mangialasche; R Camarda; U Senin; P Mecocci Journal: Acta Psychiatr Scand Date: 2008-03-19 Impact factor: 6.392
Authors: J Vilalta-Franch; M Lozano-Gallego; M Hernández-Ferrándiz; J Llinàs-Reglà; S López-Pousa; O L López Journal: Rev Neurol Date: 1999 Jul 1-15 Impact factor: 0.870
Authors: G B Frisoni; L Rozzini; A Gozzetti; G Binetti; O Zanetti; A Bianchetti; M Trabucchi; J L Cummings Journal: Dement Geriatr Cogn Disord Date: 1999 Mar-Apr Impact factor: 2.959
Authors: S Reyes; A Viswanathan; O Godin; C Dufouil; S Benisty; K Hernandez; A Kurtz; E Jouvent; M O'Sullivan; V Czernecki; M G Bousser; M Dichgans; H Chabriat Journal: Neurology Date: 2009-03-10 Impact factor: 9.910
Authors: Elisabeth C W van Straaten; Philip Scheltens; Dirk L Knol; Mark A van Buchem; Ewout J van Dijk; Paul A M Hofman; Giorgos Karas; Olafur Kjartansson; Frank-Erik de Leeuw; Niels D Prins; Reinhold Schmidt; Marieke C Visser; Henry C Weinstein; Frederik Barkhof Journal: Stroke Date: 2003-07-10 Impact factor: 7.914
Authors: M Ikeda; R Fukuhara; K Shigenobu; K Hokoishi; N Maki; A Nebu; K Komori; H Tanabe Journal: J Neurol Neurosurg Psychiatry Date: 2004-01 Impact factor: 10.154
Authors: Luis Agüera-Ortiz; Ganesh M Babulal; Marie-Andrée Bruneau; Byron Creese; Fabrizia D'Antonio; Corinne E Fischer; Jennifer R Gatchel; Zahinoor Ismail; Sanjeev Kumar; William J McGeown; Moyra E Mortby; Nicolas A Nuñez; Fabricio F de Oliveira; Arturo X Pereiro; Ramit Ravona-Springer; Hillary J Rouse; Huali Wang; Krista L Lanctôt Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160